Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring - A one year follow-up

Anticancer Research

Volumn 17, Issue 3 A, 1997, Pages 1511-1515

  Lee, Fred ^a   Bahn, Duke K ^a   Mchugh, Timothy A ^a   Kumar, Anil A ^a   Badalament, Robert A ^a  

^a Crittenton Hospital Medical Center   (United States)

Author keywords

Androgen ablation therapy; Cryosurgery; Prostate cancer; Thermosensors

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CRYOSURGERY; FOLLOW UP; FREEZING; HORMONAL THERAPY; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM FISTULA; TEMPERATURE MEASUREMENT; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CRYOSURGERY; FLUTAMIDE; FOLLOW-UP STUDIES; GOSERELIN; HUMANS; LEUPROLIDE; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0030994147     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wingo PA, Tong T, Boring S: Cancer Statistics. Ca Cancer J Clin 45: 8-30, 1995.
2. Paulson DF, Moul JW, Walther PJ: Radical prostatectomy for clinical stage T1-T2 No Mo prostatic adenocarcinoma: long-term results. J Urol 144: 1180-1184, 1990.
3. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269: 2650-2658, 1993.
4. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS: Screening for prostate cancer. A decision analytic view. JAMA 272: 773-780, 1994.
5. Gonder M, Soanes W, Shulman S: Cryosurgical treatment of the prostate. Invest Urol 3: 372-378, 1966.
6. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J: Transrectal ultrasound guided percutaneous radical cryosurgical ablation ofthe prostate. Cancer 72: 1291-1298, 1993.
7. Wieder J, Schmidt JD, Casola G, vanSonnenberg E, Stainken BF, Parsons CL: Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 154: 435-441, 1995.
8. Miller RJ, Cohen JK, Merlotti LA: Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma ofthe prostate. Urology 44: 170-174, 1994.
9. Grampsas S, Miller G, Crawford E: Salvage radical prostatectomy after failed transperineal cryotherapy: Histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology 45: 936-941, 1995.
10. Cox RL, Crawford ED: Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma ofthe prostate. Urology 45: 932-935, 1995.
11. Lee F, Bahn DK, McHugh TA, Onik, Lee FT Jr. How I Do It. US-guided percutaneous cryoablation of prostate cancer. Radiology 192: 769-776, 1994.
12. Bahn D, Lee F, Solomon M, Gontina H, Klionsky D, Lee FT: Prostate Cancer: US-guided percutaneous cryoablation. Radiology 190: 551-556, 1994.
13. Farrant J, Walter CA: The cyrobiological basis for cryosurgery. J Dermatol Surg One 3: 403-407, 1977.
14. Epstein JI, Carmichael M, Partin AW, Patrick CW: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J Urol 149: 1478-1491, 1993.
15. Paulson DP, Moul JW, Walther PJ: Radical prostatectomy for clinical stage T 1 -2 NOMO. Prostatic adenocarcinoma long term results. J Urol 144: 1180-1184, 1990.
16. Lerner SE, Blute ML, Zincke H: Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 154: 1447-1452, 1995.
17. Stamey TA, Villers AA, McNeal JE, et al: Positive surgical margins at radical prostatectomy: Importance of the apical dissection. J Urol 143: 1166, 1990.
18. Bosch RJ, Kurth KH, Schroeder FH: Surgical treatment of locally advanced (T3) prostatic carcinoma: Early results. J Urol 138: 816-822, 1987.
19. Holzman M, Carlton CE Jr, Scardino FT: The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 146: 1578-1582, 1991.
20. Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA: Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostatespecificantigen. J Urol 142: 326-331, 1989.
21. Wake RW, Hollabaugh RS Jr, Bond KH: Cryosurgical ablation ofthe prostate for localized adenocarcinoma: A preliminary experience. J Urol 155: 1663-1666, 1996.
22. Shinohara K, Connolly JA, Presti JC Jr, Carroll PR: Cryosurgical treatment of localized prostatecancer (StagesT1 toT4): Preliminaryresults. J Urol 156: 115-121, 1996.
23. Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW: Shortterm outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology 46: 676-680, 1995.